Modification of the genetic program of human alveolar macrophages by adenovirus vectors <i>in vitro</i> is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor
Downregulation of CXCR4 gene expression in primary human endothelial cells following infection with E1<SUP>-</SUP>E4<SUP>+</SUP> adenovirus gene transfer vectors